Minoleksin is a tetracycline group antibiotic which has bacteriostatic effect; it quickly penetrates through lipid layer of bacteria and cumulates actively in oil glands eliminating external symptoms of acne rash.
Registration number: LP-001666
During clinical surveys where patients with moderate and medium severity of acne rash participated, it was found that efficiency of treatment (reduction of damage) carried out with minoleksin(100 mg per day during 4 weeks then 50 mg per day during 8 weeks) was higher than efficiency of treatment carried out with lymecycline (300 mg per day during 12 weeks).
Besides, during two other clinical surveys where minoleksin and tetracycline were used during 6 weeks the best effect was visible in group taking minoleksin.
Also it was observed that patients who had been taking minoleksin during four weeks had had more evident results than those who had been taking oxytetracycline during the same period.
Measuring of medical products:
Minoleksin is produced in 50 mg and 100 mg capsules. It is dry-filled capsule #2 with body and yellow lid (for dose of 50 mg), #0 with body and white lid (for dose of 100 mg). The capsule contains powder of yellow colour5.
Main indications for use:
Minocycline hydrochloride is used for treatment of the following diseases (in case of pathogenic microorganism sensitivity):
All indications for use (see USPI).
The initial dose of Minoleksin constitutes 200 mg (two 100 mg capsules or four 50 mg capsules), then it should be taken 100 mg (one 100 mg capsule or two 50 mg capsules) per every 12 hours (two times a day).
The highest dose should not exceed 400 mg per day.